Source: European Medicines Agency (EU) Revision Year: 2015 Publisher: Mitsubishi Tanabe Pharma Europe Ltd., Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom Tel: +44 (0)207 065 5000 Fax: +44 (0)207 065 5050 Email: info@mt-pharma-eu.com
BindRen 1 g film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White, oval shaped, film-coated tablet approximately 20.2 mm in length and 10.7 mm wide printed with “BINDREN” (in blue ink) on one side. |
Each film-coated tablet contains 1 g colestilan.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Colestilan |
Colestilan is a non-absorbed, non-calcium, non-metallic phosphate-binding polymer. The binding sites become partially protonated in the stomach and interact through ionic and hydrogen bonding with both dietary phosphate anions and bile acids in the duodenum. By binding phosphate from food in the digestive tract, colestilan lowers the serum phosphorus concentration. Colestilan also binds bile acids, thereby lowering the serum LDL-cholesterol concentration. |
| List of Excipients |
|---|
|
Tablet core: Purified water Film-coating: Hypromellose Printing ink: Shellac |
High density polyethylene (HDPE) bottles, with a polypropylene cap and an induction seal.
Aluminium/polychlorotrifluoroethylene/PVC blister.
Pack sizes of 45, 99, 198, 270 or 297 tablets per carton.
Not all pack sizes may be marketed.
Mitsubishi Tanabe Pharma Europe Ltd., Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom
Tel: +44 (0)207 065 5000
Fax: +44 (0)207 065 5050
Email: info@mt-pharma-eu.com
EU/1/12/804/001-010
Date of first authorisation: 21 January 2013
| Drug | Countries | |
|---|---|---|
| BINDREN | Estonia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
